サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446459

頭蓋内動脈瘤の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント動向：2024年～2030年

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 137 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
頭蓋内動脈瘤の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント動向：2024年～2030年
出版日: 2024年02月02日
発行: Grand View Research
ページ情報: 英文 137 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

頭蓋内動脈瘤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の頭蓋内動脈瘤市場規模は2023年から2030年にかけてCAGR 9.08％を記録し、2030年までに23億3,000万米ドルに達すると予測されています。

同市場の成長は、脳卒中症例の増加、脳血管障害を患う人々の発生率の増加、主要企業による継続的な製品の発売など、さまざまな要因によるものです。さらに、可処分所得水準が拡大し、ヘルスケアへのアクセスが改善した新興国市場でも急速に成長しています。現在、脳動脈瘤の原因は明確に解明されていないです。しかし、加齢、脳外傷、遺伝性、高血圧、動脈硬化、感染症、座りっぱなしのライフスタイルなど、この症状に関連するさまざまな要因があります。注目すべき症状は、脳神経の機能障害、局所的な頭痛、複視などです。

その結果、頭蓋内動脈瘤に罹患する人口の増加が市場の拡大に寄与しています。この分野の企業は、既存の治療法をより安全で効果的なものにすると同時に、新しい技術を導入する方法を常に模索しており、これが頭蓋内動脈瘤製品に対する需要を世界的に増加させると予想されます。例えば、2022年6月には、イIndia MedtronicがCEマークを取得した第4世代の流路偏向器「Pipeline Vantage with Shield Technology」が脳動脈瘤の血管内治療用に開発されました。新たに開発されたフローディフレクターであるパイプラインバンテージは、シールドテクノロジーを搭載し、デリバリーシステムとインプラントの両方の設計の特徴を強化しています。標的血管の最内層で細胞の発達を促進する足場を開発することで、医師が脳動脈瘤や頭蓋内動脈瘤を送達、展開、修復することをより容易かつ確実にします。

頭蓋内動脈瘤市場レポート・ハイライト

  • 2023年には、血管内コイリングセグメントが84.6%のシェアを占め、市場を独占しました。これは、低侵襲脳神経外科手術への応用が増加し、遠隔地にある複数の動脈瘤に容易にアクセスできるためです。
  • 病院の最終用途セグメントは2023年に89.52％の最大の収益シェアを占めました。頭蓋内動脈瘤手術は最も複雑な手術の一つであり、病院で利用可能な高品質で耐久性のある機器に依存しています。
  • 北米が2023年に26.65%のシェアを占め、市場を独占しています。同市場は競争が激しく、既存企業も新興企業も製品のイノベーション、合併、買収、提携を通じて業界シェアの獲得に努めています。
  • そのため、北米には主要企業が存在し、同地域の市場成長を後押しすると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 頭蓋内動脈瘤の市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 頭蓋内動脈瘤市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 価格分析

第4章 頭蓋内動脈瘤市場：タイプの推定・動向分析

  • タイプ市場シェア、2023年および2030年
  • セグメントダッシュボード
  • タイプ別の世界の頭蓋内動脈瘤市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • 脳動脈クリッピング術
    • コイル塞栓術
    • フローダイバーター
    • その他

第5章 頭蓋内動脈瘤市場：最終用途推定・動向分析

  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の頭蓋内動脈瘤市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで
    • 病院
    • クリニック
    • その他

第6章 頭蓋内動脈瘤市場：地域推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Medtronic plc
    • Stryker Corporation
    • MicroPort Scientific Corporation.
    • Johnson &Johnson Services, Inc.
    • MicroVention Inc.
    • B. Braun Melsungen AG
    • Integra LifeSciences
    • RAUMEDIC AG
    • Terumo Corporation
    • Delta Surgical
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 11 Europe Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Germany Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 17 France Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 China Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 32 China Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 36 India Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 South Korea Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 38 South Korea Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Australia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 40 Australia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 45 Latin America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 54 MEA Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Intracranial aneurysm market: market outlook
  • Fig. 14 Intracranial aneurysm competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Intracranial aneurysm market driver impact
  • Fig. 20 Intracranial aneurysm market restraint impact
  • Fig. 21 Intracranial aneurysm market strategic initiatives analysis
  • Fig. 22 Intracranial aneurysm market: Type movement analysis
  • Fig. 23 Intracranial aneurysm market: Type outlook and key takeaways
  • Fig. 24 Surgical Clipping market estimates and forecast, 2018 - 2030
  • Fig. 25 Endovascular Coiling market estimates and forecast, 2018 - 2030
  • Fig. 26 Flow Diverters market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Intracranial aneurysm market: End-use movement analysis
  • Fig. 29 Intracranial aneurysm market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 32 Others market estimates and forecasts,2018 - 2030
  • Fig. 33 Global Intracranial aneurysm market: Regional movement analysis
  • Fig. 34 Global Intracranial aneurysm market: Regional outlook and key takeaways
  • Fig. 35 Global Intracranial aneurysm market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France market estimates and forecasts, 2018 - 2030
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 India market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 69 Market share of key market players- Intracranial aneurysm market
目次
Product Code: GVR-4-68038-416-1

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights:

  • In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas
  • The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals
  • North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships
  • Thus, the presence of key players in North America is expected to boost the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intracranial aneurysm Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of neurological diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing preference for targeted therapy approach
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of DBS surgery
      • 3.2.2.2. Complex regulatory framework
  • 3.3. Intracranial aneurysm Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Pricing Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Intracranial aneurysm Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Intracranial aneurysm Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Surgical Clipping
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Endovascular Coiling
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Flow Diverters
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intracranial aneurysm Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Intracranial aneurysm Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Clinics
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intracranial aneurysm Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic plc
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Stryker Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MicroPort Scientific Corporation.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Johnson & Johnson Services, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. MicroVention Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. B. Braun Melsungen AG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Integra LifeSciences
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. RAUMEDIC AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Terumo Corporation
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Delta Surgical
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives